Commerzbank Aktiengesellschaft’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.25M | Sell |
13,589
-788
| -5% | -$292K | 0.11% | 90 |
|
|
2026
Q1 | $4.21M | Buy |
14,377
+8,946
| +165% | +$2.94M | 0.09% | 99 |
|
|
2025
Q4 | $1.9M | Buy |
5,431
+2,471
| +83% | +$835K | 0.04% | 171 |
|
|
2025
Q3 | $957K | Hold |
2,960
| – | – | 0.02% | 222 |
|
|
2025
Q2 | $1.15M | Sell |
2,960
-29
| -1% | -$11.7K | 0.03% | 174 |
|
|
2025
Q1 | $1.3M | Buy |
2,989
+1,075
| +56% | +$432K | 0.03% | 153 |
|
|
2024
Q4 | $706K | Buy |
1,914
+477
| +33% | +$200K | 0.02% | 184 |
|
|
2024
Q3 | $748K | Buy |
1,437
+374
| +35% | +$200K | 0.02% | 158 |
|
|
2024
Q2 | $576K | Sell |
1,063
-794
| -43% | -$420K | 0.02% | 150 |
|
|
2024
Q1 | $963K | Buy |
1,857
+990
| +114% | +$492K | 0.03% | 106 |
|
|
2023
Q4 | $409K | Buy |
+867
| New | +$401K | 0.02% | 129 |
|
|
2020
Q1 | – | Sell |
-7,845
| Closed | -$2.37M | – | 532 |
|
|
2019
Q4 | $2.37M | Buy |
7,845
+63
| +0.8% | +$17.3K | 0.02% | 316 |
|
|
2019
Q3 | $1.87M | Buy |
7,782
+2,686
| +53% | +$736K | 0.01% | 433 |
|
|
2019
Q2 | $1.44M | Buy |
5,096
+236
| +5% | +$64.5K | 0.01% | 531 |
|
|
2019
Q1 | $1.4M | Sell |
4,860
-1,102
| -18% | -$319K | 0.01% | 453 |
|
|
2018
Q4 | $1.57M | Buy |
5,962
+1,785
| +43% | +$491K | 0.02% | 455 |
|
|
2018
Q3 | $1.15M | Sell |
4,177
-609
| -13% | -$158K | 0.01% | 541 |
|
|
2018
Q2 | $1.14M | Sell |
4,786
-2,077
| -30% | -$481K | 0.01% | 504 |
|
|
2018
Q1 | $1.51M | Buy |
6,863
+3,944
| +135% | +$926K | 0.02% | 463 |
|
|
2017
Q4 | $657K | Sell |
2,919
-208
| -7% | -$44.3K | 0.01% | 610 |
|
|
2017
Q3 | $594K | Buy |
3,127
+2,002
| +178% | +$381K | 0.01% | 571 |
|
|
2017
Q2 | $212K | Sell |
1,125
-6,856
| -86% | -$1.23M | ﹤0.01% | 661 |
|
|
2017
Q1 | $1.32M | Buy |
7,981
+4,082
| +105% | +$649K | 0.02% | 432 |
|
|
2016
Q4 | $561K | Sell |
3,899
-186
| -5% | -$24.9K | 0.01% | 578 |
|
|
2016
Q3 | $512K | Sell |
4,085
-76,595
| -95% | -$9.89M | 0.01% | 564 |
|
|
2016
Q2 | $10.6K | Buy |
80,680
+40,132
| +99% | +$5.49M | 0.07% | 153 |
|
|
2016
Q1 | $5.64M | Buy |
40,548
+25,539
| +170% | +$3.41M | 0.05% | 219 |
|
|
2015
Q4 | $2.09M | Buy |
15,009
+7,042
| +88% | +$970K | 0.02% | 483 |
|
|
2015
Q3 | $1.11M | Sell |
7,967
-20,275
| -72% | -$3.05M | 0.01% | 554 |
|
|
2015
Q2 | $4.64M | Sell |
28,242
-4,951
| -15% | -$791K | 0.02% | 382 |
|
|
2015
Q1 | $5.13M | Sell |
33,193
-148,623
| -82% | -$21.2M | 0.03% | 360 |
|
|
2014
Q4 | $22.8M | Buy |
181,816
+90,412
| +99% | +$11.2M | 0.15% | 117 |
|
|
2014
Q3 | $10.9M | Buy |
91,404
+8,232
| +10% | +$944K | 0.04% | 295 |
|
|
2014
Q2 | $8.95M | Sell |
83,172
-9,781
| -11% | -$1.01M | 0.05% | 297 |
|
|
2014
Q1 | $9.25M | Buy |
92,953
+2,839
| +3% | +$257K | 0.04% | 273 |
|
|
2013
Q4 | $7.75M | Sell |
90,114
-194,448
| -68% | -$17.3M | 0.04% | 322 |
|
|
2013
Q3 | $23.8M | Buy |
284,562
+149,926
| +111% | +$12.8M | 0.12% | 147 |
|
|
2013
Q2 | $11M | Buy |
+134,636
| New | +$10.1M | 0.05% | 290 |
|
Other funds holding ELV
N
Commerzbank Aktiengesellschaft's ELV Position: Q2 2026 in Review
Commerzbank Aktiengesellschaft reduced its Elevance Health (ELV) stake by 5.5% in Q2 2026, selling an estimated $292K and leaving 13,589 shares worth $5.25M. The position accounts for 0.11% of the portfolio, ranked #90.
Commerzbank Aktiengesellschaft first reported a position in ELV in Q2 2013 and has held it in 38 quarters since. The position peaked at $23.8M in Q3 2013. 1,076 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Commerzbank Aktiengesellschaft held 13,589 shares of Elevance Health worth $5.25M as of Q2 2026.
- Commerzbank Aktiengesellschaft sold 788 Elevance Health shares in Q2 2026, an estimated $292K.
- Elevance Health made up 0.11% of Commerzbank Aktiengesellschaft's portfolio in Q2 2026, its #90 holding.
- Commerzbank Aktiengesellschaft first reported a position in Elevance Health in Q2 2013 and has held it in 38 quarters since.
- Commerzbank Aktiengesellschaft's Elevance Health position peaked at $23.8M in Q3 2013.
- 1,076 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Commerzbank Aktiengesellschaft's 13F filing for Q2 2026, filed 7 Aug 2026.